Motixafortide
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Motixafortide, covering 2025-03-21 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Motixafortide for MRD Sensitization in AML [Phase 2]